Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
79,643,662
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
7,884,710
-
Shares change
-
-628,328
-
Total reported value, excl. options
-
$34,745,775
-
Value change
-
-$3,532,209
-
Number of buys
-
13
-
Number of sells
-
-7
-
Price
-
$4.41
Significant Holders of Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) as of Q4 2021
38 filings reported holding ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,884,710 shares
of 79,643,662 outstanding shares and own 9.9% of the company stock.
Largest 10 shareholders include BVF INC/IL (1,378,020 shares), Logos Global Management LP (1,339,793 shares), Cormorant Asset Management, LP (1,305,095 shares), Woodline Partners LP (781,376 shares), VANGUARD GROUP INC (669,700 shares), FMR LLC (504,371 shares), Point72 Asset Management, L.P. (431,435 shares), Ikarian Capital, LLC (344,578 shares), TWO SIGMA ADVISERS, LP (127,600 shares), and GEODE CAPITAL MANAGEMENT, LLC (126,710 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.